[Hyperlipidemia and coronary heart disease]

Area of Science:

• Cardiovascular Medicine
• Lipid Metabolism
• Atherosclerosis Research

Background:

• Coronary heart disease (CHD) is a leading cause of mortality in Western countries.
• High cholesterol and low-density lipoprotein (LDL) levels are strongly implicated in the development of atherosclerosis.
• Atherosclerosis is a key pathological process underlying CHD.

Purpose of the Study:

• To summarize the established role of cholesterol and LDL in atherosclerosis.
• To highlight the association between lipid-lowering therapies and reduced CHD risk.

Main Methods:

• Review of existing scientific and medical literature.
• Consensus-based understanding of lipid metabolism and cardiovascular disease.

Main Results:

• Cholesterol and LDL are dominant factors in atherosclerosis.
• Lipid-lowering agents demonstrate a correlation with decreased CHD risk.

Conclusions:

• Managing cholesterol and LDL levels is crucial for preventing CHD.
• Lipid-lowering therapies represent a significant strategy in cardiovascular disease management.